Key Points
- Director Terry Yanofsky sold 14,920 Canopy Growth shares at an average price of C$1.29, totaling C$19,246.80. His remaining stake fell 16.17% to 77,333 shares.
- Canopy Growth reported quarterly revenue of C$81.17 million and a loss of C$0.03 per share, while maintaining sharply negative profitability metrics, including a 73.95% negative net margin.
- Analysts hold a consensus “Moderate Buy” rating with an average price target of C$1.88, despite Alliance Global Partners reducing its target from C$1.80 to C$1.60.
Canopy Growth Corp (TSE:WEED - Get Free Report) Director Terry Yanofsky sold 14,920 shares of the firm's stock in a transaction dated Monday, September 28th. The stock was sold at an average price of C$1.29, for a total value of C$19,246.80. Following the transaction, the director owned 77,333 shares of the company's stock, valued at C$99,759.57. This trade represents a 16.17% decrease in their ownership of the stock.
Canopy Growth Price Performance
Canopy Growth stock opened at C$1.27 on Thursday. The stock's 50 day moving average is C$1.34 and its 200 day moving average is C$1.40. Canopy Growth Corp has a one year low of C$1.18 and a one year high of C$3.28. The firm has a market cap of C$537.26 million, a P/E ratio of -1.90, a P/E/G ratio of -0.01 and a beta of 1.63. The company has a debt-to-equity ratio of 40.27, a current ratio of 3.04 and a quick ratio of 2.32.
Canopy Growth (TSE:WEED - Get Free Report) last released its earnings results on Friday, August 7th. The company reported C($0.03) earnings per share for the quarter. Canopy Growth had a negative net margin of 73.95% and a negative return on equity of 29.85%. The firm had revenue of C$81.17 million for the quarter. As a group, research analysts expect that Canopy Growth Corp will post -0.69 EPS for the current year.
Wall Street Analyst Weigh In
Separately, Alliance Global Partners decreased their price target on Canopy Growth from C$1.80 to C$1.60 in a report on Tuesday, June 16th. Two investment analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat, Canopy Growth currently has an average rating of "Moderate Buy" and a consensus price target of C$1.88.
Read Our Latest Stock Analysis on WEED
About Canopy Growth
(
Get Free Report)
Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, CraftGrow, and Foria brand names. It also offers its products through Tweed Main Street, a single online platform that enables registered patients to purchase medicinal cannabis from various producers across various brands.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
